| Target Price | $291.21 |
| Price | $265.10 |
| Potential |
9.85%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target CME Group a 2027 .
The average CME Group a target price is $291.21.
This is
9.85%
register free of charge
$346.50
30.71%
register free of charge
$232.30
12.37%
register free of charge
|
|
| A rating was issued by 21 analysts: 11 Analysts recommend CME Group a to buy, 7 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CME Group a stock has an average upside potential 2027 of
9.85%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 11.95 | 7.09 |
| 17.06% | 40.65% | |
| EBITDA Margin | 83.60% | 71.25% |
| 2.24% | 14.77% | |
| Net Margin | 33.65% | 62.67% |
| 1.34% | 86.26% |
18 Analysts have issued a sales forecast CME Group a 2026 . The average CME Group a sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an CME Group a EBITDA forecast 2026. The average CME Group a EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
19 CME Group a Analysts have issued a net profit forecast 2026. The average CME Group a net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 11.16 | 12.37 |
| 15.41% | 10.84% | |
| P/E | 21.43 | |
| EV/Sales | 13.61 |
19 Analysts have issued a CME Group a forecast for earnings per share. The average CME Group a EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| TD Cowen |
Locked
➜
Locked
|
Locked | Sep 28 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Sep 03 2026 |
| Deutsche Bank |
Locked
➜
Locked
|
Locked | Aug 19 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Jul 15 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
TD Cowen:
Locked
➜
Locked
|
Sep 28 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Sep 03 2026 |
|
Locked
Deutsche Bank:
Locked
➜
Locked
|
Aug 19 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Jul 23 2026 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Jul 23 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 23 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Jul 15 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


